Verastem, Inc. To Present Data On Product Candidates Targeting Cancer Stem Cells At The American Association for Cancer Research Meeting

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that the Company will present data at the upcoming American Association of Cancer Research (AACR) meeting to be held April 5-9, 2014 at the San Diego Convention Center in San Diego, CA.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC